Prestige Biologics Statistics

Total Valuation

KOSDAQ:334970 has a market cap or net worth of KRW 282.19 billion. The enterprise value is 362.96 billion.

Market Cap	282.19B
Enterprise Value	362.96B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:334970 has 77.42 million shares outstanding. The number of shares has increased by 18.92% in one year.

Current Share Class	77.42M
Shares Outstanding	77.42M
Shares Change (YoY)	+18.92%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	20.32%
Owned by Institutions (%)	0.04%
Float	27.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	42.05
PB Ratio	2.11
P/TBV Ratio	2.13
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.02
EV / Sales	54.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.62

Financial Position

The company has a current ratio of 0.45, with a Debt / Equity ratio of 0.68.

Current Ratio	0.45
Quick Ratio	0.14
Debt / Equity	0.68
Debt / EBITDA	n/a
Debt / FCF	-4.16
Interest Coverage	-3.05

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-18.56%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.57% in the last 52 weeks. The beta is 1.04, so KOSDAQ:334970's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	-8.57%
50-Day Moving Average	3,989.10
200-Day Moving Average	5,049.23
Relative Strength Index (RSI)	32.41
Average Volume (20 Days)	126,794

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:334970 had revenue of KRW 6.71 billion and -32.95 billion in losses. Loss per share was -472.27.

Revenue	6.71B
Gross Profit	-17.72B
Operating Income	-31.37B
Pretax Income	-32.95B
Net Income	-32.95B
EBITDA	-18.30B
EBIT	-31.37B
Loss Per Share	-472.27

Full Income Statement

Balance Sheet

The company has 10.11 billion in cash and 90.88 billion in debt, giving a net cash position of -80.77 billion or -1,043.31 per share.

Cash & Cash Equivalents	10.11B
Total Debt	90.88B
Net Cash	-80.77B
Net Cash Per Share	-1,043.31
Equity (Book Value)	133.65B
Book Value Per Share	1,726.37
Working Capital	-60.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.81 billion and capital expenditures -7.03 billion, giving a free cash flow of -21.84 billion.

Operating Cash Flow	-14.81B
Capital Expenditures	-7.03B
Free Cash Flow	-21.84B
FCF Per Share	-282.10

Full Cash Flow Statement

Margins

Gross Margin	-264.00%
Operating Margin	-467.44%
Pretax Margin	-490.91%
Profit Margin	n/a
EBITDA Margin	-272.76%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:334970 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.92%
Shareholder Yield	n/a
Earnings Yield	-11.67%
FCF Yield	-7.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:334970 has an Altman Z-Score of -0.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.41
Piotroski F-Score	2